Alps Advisors Inc Durect Corp Transaction History

Alps Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$0.48 - $1.1 $137,608 - $315,352	-286,684 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$1.06 - $1.69 $55,114 - $87,871	51,995 Added 22.15%	286,684 $315,000
Q2 2018 Aug 02, 2018	BUY	$1.56 - $2.51 $366,114 - $589,069	234,689 New	234,689 $366,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $194M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.